C4 Therapeutics Inc.
Organization details
- Legal name
- C4 Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Watertown
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- CCCC
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001662579
- EIN
- 47-5617627
- Wikidata ID
- Q64142088
Board of directors
-
Andrew Hirsch · Director · President & CEOSince 2023
-
Bruce Downey · DirectorSince 2023
-
Donna Roy Grogan · DirectorSince 2023
-
Glenn Dubin · DirectorSince 2023
-
Kenneth Carl Anderson · DirectorSince 2023
-
Laura Bessen · DirectorSince 2023
-
Malcolm Salter · DirectorSince 2023
-
Owen Hughes · DirectorSince 2023
-
Ronald Harold Wilfred Cooper · DirectorSince 2024
-
Stephen Fawell · DirectorSince 2024
-
Steven L. Hoerter · DirectorSince 2024
-
Utpal Koppikar · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 24, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
83.0%
-
85.3%
-
85.3%
Board connections
7 of this board's directors also sit on 10 other boards. 10 are in the same sector.
-
AnaptysBio Inc. Same sectorvia Owen Hughes
-
Artiva Biotherapeutics Inc. Same sectorvia Laura Bessen
-
Cardinal Health Inc. Same sectorvia Bruce Downey
-
Editas Medicine Inc. Same sectorvia Andrew Hirsch
-
ImageneBio Inc. Same sectorvia Owen Hughes
-
Insmed Incorporated Same sectorvia Utpal Koppikar
-
MBX Biosciences Inc. Same sectorvia Steven L. Hoerter
-
Oric Pharmaceuticals Inc. Same sectorvia Steven L. Hoerter
-
Yarrow Bioscience Inc. Same sectorvia Steven L. Hoerter
-
enGene Therapeutics Inc. Same sectorvia Ronald Harold Wilfred Cooper
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $22,200
- 1 sale by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 1, 2026 | Kenneth Carl Anderson Director | Grant or award | +3,662 | $3.14 | $11,499 |
| Oct 1, 2026 | Donna Roy Grogan Director | Grant or award | +4,618 | $3.14 | $14,501 |
| Sep 18, 2026 | Adams Kendra Officer (Chief Financial Officer) | Option exercise | +6,250 | — | — |
| Sep 18, 2026 | Adams Kendra Officer (Chief Financial Officer) | Shares withheld for tax | −2,775 | $3.39 | $9,407 |
| Jul 10, 2026 | REYNO LEONARD Officer (Chief Medical Officer) | Option exercise | +15,325 | — | — |
| Jul 10, 2026 | REYNO LEONARD Officer (Chief Medical Officer) | Shares withheld for tax | −7,397 | $4.06 | $30,032 |
| Jul 1, 2026 | Kenneth Carl Anderson Director | Grant or award | +2,650 | $4.34 | $11,501 |
| Jul 1, 2026 | Donna Roy Grogan Director | Grant or award | +3,341 | $4.34 | $14,500 |
| Jun 1, 2026 | Kenneth Carl Anderson Director | Option exercise | +1,070 | $2.11 | $2,258 |
| Apr 1, 2026 | Kenneth Carl Anderson Director | Grant or award | +4,259 | $2.70 | $11,499 |
| Apr 1, 2026 | Donna Roy Grogan Director | Grant or award | +5,370 | $2.70 | $14,499 |
| Feb 15, 2026 | Andrew Hirsch Director, Officer (President & CEO) | Option exercise | +20,400 | — | — |
| Feb 15, 2026 | Andrew Hirsch Director, Officer (President & CEO) | Shares withheld for tax | −9,057 | $1.89 | $17,118 |
| Feb 14, 2026 | Mahaney Paige Officer (Chief Scientific Officer) | Option exercise | +7,050 | — | — |
| Feb 14, 2026 | Andrew Hirsch Director, Officer (President & CEO) | Option exercise | +81,725 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about C4 Therapeutics Inc.
Who is the CEO of C4 Therapeutics Inc.?
Andrew Hirsch is C4 Therapeutics Inc.'s President & CEO.
How many directors are on C4 Therapeutics Inc.'s board?
C4 Therapeutics Inc.'s board has 12 directors: Andrew Hirsch, Bruce Downey, Donna Roy Grogan, Glenn Dubin, Kenneth Carl Anderson, Laura Bessen, Malcolm Salter, Owen Hughes, Ronald Harold Wilfred Cooper, Stephen Fawell and 2 others.
Are C4 Therapeutics Inc. insiders buying or selling shares?
Over the last 12 months, C4 Therapeutics Inc. insiders made no open-market purchases and sold $22,200 of shares in 1 sale on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="c4-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.